Literature DB >> 30603286

Serum uric acid levels are associated with a high risk of rapid chronic kidney disease progression among patients with type 2 diabetes: a prospective cohort study [Diabetes Distress and Care Registry at Tenri (DDCRT 12)].

Hirohito Kuwata1, Shintaro Okamura1, Yasuaki Hayashino1, Hitoshi Ishii2, Satoru Tsujii1.   

Abstract

BACKGROUND: We assessed the prospective association between baseline serum uric acid (SUA) concentrations and consequent risk of chronic kidney disease (CKD) progression in type 2 diabetes patients.
METHODS: Longitudinal data from a Japanese diabetes registry including 3454 type 2 diabetes patients were obtained. To assess the independent correlations between SUA and rapid CKD progression [i.e., 30 % reduction in estimated glomerular filtration rate (eGFR) over 2 years], participants were divided into five groups based on SUA levels: <5.0, ≥5.0-6.0, ≥6.0-7.0, ≥7.0-8.0, and ≥8.0 mg/dl. Cox proportional hazards model adjusted for potential confounders was used for analysis.
RESULTS: After 2 years, rapid CKD progression was recognized in 169 patients (4.89 %) who showed longer duration of type 2 diabetes (15.5 vs. 13.5 years, p = 0.005); higher systolic blood pressure (142.0 vs. 138.3 mmHg, p = 0.016), SUA (6.15 vs. 5.32 mg/dl, p < 0.001), and urinary albumin-creatinine ratio (1127.4 vs. 184.7 mg/gCr, p < 0.001); and lower diastolic blood pressure (69.7 vs. 72.8 mmHg, p = 0.003). Multivariate ratios for rapid CKD progression were 1.19 (p = 0.371), 1.02 (p = 0.937), 1.18 (p = 0.625), and 3.04 (p = 0.004), respectively, for the first, third, fourth, and fifth serum UA range groups; a second group was used as a reference.
CONCLUSIONS: Higher SUA levels, independent of possible confounders, were associated with rapid eGFR decline and CKD progression in type 2 diabetes patients. SUA may be a useful biomarker for predicting future risk of rapid diabetic CKD progression.

Entities:  

Keywords:  Chronic kidney disease; Cohort; Epidemiology; Human; Type 2 diabetes; Uric acid

Year:  2016        PMID: 30603286      PMCID: PMC6224962          DOI: 10.1007/s13340-016-0254-2

Source DB:  PubMed          Journal:  Diabetol Int        ISSN: 2190-1678


  42 in total

Review 1.  Nephropathy in patients with type 2 diabetes mellitus.

Authors:  E Ritz; S R Orth
Journal:  N Engl J Med       Date:  1999-10-07       Impact factor: 91.245

2.  Progression of diabetic nephropathy.

Authors:  P Hovind; P Rossing; L Tarnow; U M Smidt; H H Parving
Journal:  Kidney Int       Date:  2001-02       Impact factor: 10.612

Review 3.  Unearthing uric acid: an ancient factor with recently found significance in renal and cardiovascular disease.

Authors:  T Nakagawa; D-H Kang; D Feig; L G Sanchez-Lozada; T R Srinivas; Y Sautin; A A Ejaz; M Segal; R J Johnson
Journal:  Kidney Int       Date:  2006-05       Impact factor: 10.612

Review 4.  Uric acid, the metabolic syndrome, and renal disease.

Authors:  Pietro Cirillo; Waichi Sato; Sirirat Reungjui; Marcelo Heinig; Michael Gersch; Yuri Sautin; Takahiko Nakagawa; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2006-12       Impact factor: 10.121

5.  Factors affecting progression of renal failure in patients with type 2 diabetes.

Authors:  Hideki Ueda; Eiji Ishimura; Tetsuo Shoji; Masanori Emoto; Tomoaki Morioka; Naoki Matsumoto; Shinya Fukumoto; Takami Miki; Masaaki Inaba; Yoshiki Nishizawa
Journal:  Diabetes Care       Date:  2003-05       Impact factor: 19.112

6.  Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus.

Authors:  Michiaki Fukui; Muhei Tanaka; Emi Shiraishi; Ichiko Harusato; Hiroko Hosoda; Mai Asano; Mayuko Kadono; Goji Hasegawa; Toshikazu Yoshikawa; Naoto Nakamura
Journal:  Metabolism       Date:  2008-05       Impact factor: 8.694

7.  Elevated uric acid increases the risk for kidney disease.

Authors:  Rudolf P Obermayr; Christian Temml; Georg Gutjahr; Maarten Knechtelsdorfer; Rainer Oberbauer; Renate Klauser-Braun
Journal:  J Am Soc Nephrol       Date:  2008-09-17       Impact factor: 10.121

8.  Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk.

Authors:  Giuseppe Mercuro; Cristiana Vitale; Elena Cerquetani; Sandra Zoncu; Martino Deidda; Massimo Fini; Giuseppe M C Rosano
Journal:  Am J Cardiol       Date:  2004-10-01       Impact factor: 2.778

9.  Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system.

Authors:  Dalila B Corry; Pirooz Eslami; Kei Yamamoto; Michael D Nyby; Hirofumi Makino; Michael L Tuck
Journal:  J Hypertens       Date:  2008-02       Impact factor: 4.844

10.  The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study.

Authors:  William F Keane; Barry M Brenner; Dick de Zeeuw; Jean-Pierre Grunfeld; Janet McGill; William E Mitch; Artur B Ribeiro; Shahnaz Shahinfar; Roger L Simpson; Steven M Snapinn; Robert Toto
Journal:  Kidney Int       Date:  2003-04       Impact factor: 10.612

View more
  2 in total

1.  Risk Predictors of High Uric Acid Levels Among Patients with Type-2 Diabetes.

Authors:  Zobeida Eljaaly; Muhammad Mujammami; Shaik Sarfaraz Nawaz; Mohamed Rafiullah; Khalid Siddiqui
Journal:  Diabetes Metab Syndr Obes       Date:  2021-12-24       Impact factor: 3.168

2.  Distinct Prognostic Role of Serum Uric Acid Levels for Predicting All-Cause Mortality Among Chinese Adults Aged 45~75 Years With and Without Diabetes.

Authors:  Bowen Zhu; Jian Zhang; Nana Song; Yiqin Shi; Yi Fang; Xiaoqiang Ding; Yang Li
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-16       Impact factor: 6.055

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.